Share Facebook Twitter LinkedIn Pinterest Email AMN Healthcare Services beats Q3 top and bottom line estimates; initiates Q4 outlook
Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix (NASDAQ:FLGT)February 27, 2026